Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis

BACKGROUND: Tofacitinib is an oral, small molecule Janus kinase inhibitor approved in Japan for the treatment of ulcerative colitis (UC). Differences in the safety profile of tofacitinib in Japanese patients versus the global population, such as a higher risk of herpes zoster, have been reported. OB...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Inflamm Intest Dis
Main Authors: Suzuki, Yasuo, Watanabe, Mamoru, Matsui, Toshiyuki, Motoya, Satoshi, Hisamatsu, Tadakazu, Yuasa, Hirotoshi, Tabira, Junichi, Isogawa, Naoki, Tsuchiwata, Shinichi, Arai, Shoko, Hibi, Toshifumi
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6873059/
https://ncbi.nlm.nih.gov/pubmed/31768386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000502144
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados